Ro vs Medvi: Business Models, Dispensing, and Genetic Context

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This page sits within the PlexusDx Education Hub, where we unpack GLP-1 therapies, weight-management protocols, and the genetic factors behind each metabolic decision. Explore the full Peptides & GLP-1 library.

Full head-to-head: PlexusDx vs MEDVi →

What follows is independent editorial analysis. PlexusDx holds no commercial relationship with Ro or Medvi, and nothing here involves affiliate links, referral fees, or sponsored placement.

Search "Ro vs Medvi" and you are really asking a question about business models. Both are telehealth routes to GLP-1 therapy, but they are built differently: one leans on a broad subscription platform, the other on a compounding-pharmacy pipeline. This comparison walks through how each is structured, what shapes the price you pay, and one upstream factor neither is designed to measure. Details reflect the market as of April 2026.

Ro at a glance

Ro (Roman Health) runs as a subscription telehealth service spanning several categories of care. Within weight management, a program of this type generally pairs a virtual clinical evaluation with a provider-issued prescription, then routes fulfillment to either brand-name FDA-approved GLP-1 medication or compounded semaglutide or tirzepatide through licensed pharmacy channels. Current program specifics live on Ro's official website.

Medvi at a glance

Medvi (Medvi Wellness) is structured around telehealth paired with a compounding-pharmacy pathway. The mechanics — which medications are offered, how titration is supported, and what each tier costs — shift over time, so the authoritative source is Medvi's own website at the moment you evaluate it.

Where the two models diverge

The practical difference is less about the drug and more about the wrapper around it. A broad subscription platform tends to standardize intake and offer multiple service lines; a compounding-focused program concentrates on the GLP-1 pathway itself and its 503A dispensing. Neither arrangement changes the molecule you receive — it changes the provider relationship, the follow-up cadence, and how billing is packaged.

The pharmacology both share

Whatever the storefront, the underlying biology is fixed. GLP-1 receptor agonists such as semaglutide, liraglutide, and dulaglutide, along with the dual GIP/GLP-1 agonist tirzepatide, act on appetite signaling, satiety, and gastric emptying. That mechanism is a property of the compound, not the platform selling it — a point worth holding onto when a brand's marketing implies otherwise.

What drives the price you actually pay

Monthly cost in this category is a stack, not a single number: a program or membership fee, the medication itself, and any compounded-pharmacy dispensing. Because each brand publishes and revises its own figures, the reliable move is to read each pricing page directly before committing rather than trust a number quoted elsewhere. Cash-pay is the norm, and insurance rarely covers compounded GLP-1 therapy.

The genetic layer neither model includes

Here is the variable that sits above both programs. Your response to any GLP-1 pathway is shaped by inherited biology that a telehealth intake form never captures. A variant in FTO, the fat-mass and obesity-associated gene, influences baseline appetite and body-weight regulation; GLP1R encodes the very receptor these compounds target; MC4R sits at the center of satiety signaling; and TCF7L2 ties into glucose handling. The PlexusDx Precision Peptide Genetic Test reads 14 pathways, 49 peptides, 150+ genetic insights across this terrain. It does not predict how you will respond to any specific medication — it maps the biology a clinician is prescribing into.

Where PlexusDx fits

PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols — including Semaglutide Injection at $189/month and Tirzepatide Injection at $289/month, with oral options also available. The difference is sequencing: the Precision Peptide Genetic Test ($298, or $99 for program members) is meant to come first, so your protocol conversation starts from your own pathway data rather than a generic intake. Test before you invest.

No affiliation: PlexusDx is independent of both Ro and Medvi and has no commercial tie to either company discussed here.

More from the PlexusDx library: GLP 1 Drugs, GLP 1 Hormone, What Is GLP 1, and GLP 1 What Is.

Editorial note: this comparison is informational and independent. PlexusDx has no relationship with Ro or Medvi and sells semaglutide and tirzepatide through its own Weight Management Protocols. The Precision Peptide Genetic Test examines how your genes influence peptide-related pathways; it does not forecast your response to any particular drug. Speak with a licensed healthcare provider before starting any peptide protocol.

Frequently Asked Questions

Is Ro or Medvi the better choice?

Neither wins on principle. Ro leans on a broad subscription platform while Medvi centers on a compounding pathway, yet both deliver the same GLP-1 drug class. The right fit depends on your budget, the follow-up you want, and program terms you should confirm on each brand's own site.

Do Ro and Medvi prescribe different medications?

Both can route GLP-1 receptor agonists through telehealth. What differs is the dispensing lane — FDA-approved brand product versus compounded semaglutide or tirzepatide — plus subscription structure and provider type. The pharmacology itself comes from the compound, so the platform choice does not alter how the molecule works.

Does the Precision Peptide Genetic Test tell me which program to pick?

No. It does not rank telehealth programs or predict response to any compound. It reads pathway-level variants such as FTO, GLP1R, and MC4R that describe your baseline metabolic biology — context that stays relevant no matter which service ultimately writes the prescription for you.

Is compounded GLP-1 therapy covered by insurance?

Usually not. Compounded semaglutide and tirzepatide are typically cash-pay, and both Ro and Medvi publish their own pricing rather than billing insurers for compounded products. Verify current costs and any coverage details directly on each brand's website before you enroll anywhere.

This article belongs to the PlexusDx Education Hub. Browse more Peptides & GLP-1 education.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.